Retatrutide

Weight loss and appetite suppression

$160

AUD · 20mg

BAC water included free

Reference grade · For laboratory research only

Quick overview

In plain English

Weight loss and appetite suppression.

The science

Mechanism & research

Retatrutide is a triple agonist targeting the GLP-1, GIP, and glucagon receptors. Through GLP-1 and GIP activation it enhances glucose-dependent insulin secretion and slows gastric emptying, while glucagon receptor agonism increases basal energy expenditure and hepatic lipid oxidation. In phase 2 clinical research, weekly dosing produced dose-dependent reductions in body weight averaging ~17–24% at 48 weeks, alongside improvements in fasting glucose, lipid profiles, and blood pressure.

Research use disclaimer: This product is supplied strictly for in-vitro laboratory research and analytical reference. It is not a pharmaceutical, is not approved by the TGA for human therapeutic use, and must not be administered to humans or animals.

More compounds

CJC-1295 No DAC + Ipamorelin

Growth hormone boost, better sleep and recovery

$100

GHK-Cu

Younger looking skin and faster healing

$80

Melanotan 1

Deep tan, arousal boost and fat loss

$80